Dr Lal Pathlabs Ltd Share Price
(LALPATHLAB)
₹2625.45▲0.48%
as on 04:01PM, 20 Feb 2025
Dr Lal Pathlabs Ltd Performance
Day's Low
Day's High
₹2,572.5Day's Price Range₹2,64052 Week's Low
52 Week's High
₹1,943.752-Week Price Range₹3,653.95
| Returns % | |
| 1 Month Return | -7.36 % |
| 3 Month Return | -13.66 % |
| 1 Year Return | + 5.68 % |
| Market Stats | |
| Previous Close | ₹2,612.85 |
| Open | ₹2,611.90 |
| Volume | 1.16L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹21,840.22Cr |
Dr Lal Pathlabs Ltd Key Statistics
P/E Ratio
52.22
PEG Ratio
5.06
Market Cap
₹21,840.22 Cr
P/B Ratio
9.94
EPS
43.4
Dividend Yield
0.8
Sector
Healthcare
ROE
21.42
Dr Lal Pathlabs Ltd Mutual Fund Holdings
Dr Lal Pathlabs Ltd Analyst Rating
based on 23 analysts
56.52%
Buy
13.04%
Hold
30.43%
Sell
Based on 23 analysts offering long term price targets for Dr Lal Pathlabs Ltd. An average target of ₹3147.57
Source: S&P Global Market Intelligence
Dr Lal Pathlabs Ltd Share analysis
Dr Lal Pathlabs Ltd price forecast by 23 analysts
Upside of20.47%
High
₹3770
Target
₹3147.57
Low
₹2380
Dr Lal Pathlabs Ltd target price ₹3147.57, a slight upside of 20.47% compared to current price of ₹2625.45. According to 23 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Dr Lal Pathlabs Ltd revenue growth forecast
Expected growth rate Q1, FY2027:38.71%
Forecast
Actual
Including amortisation and stock based compensations
Dr Lal Pathlabs Ltd EPS growth forecast
EPS estimate Q1, FY2027:61.82%
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Dr Lal Pathlabs Ltd
Dr Lal PathLabs Declares 3rd Interim Dividend - 05 Feb, 2025
On January 30, 2025, Dr Lal PathLabs approved a 3rd Interim Dividend of ₹6 per equity share for FY 2024-25, with a record date of February 5, 2025.Dr Lal PathLabs Reports Strong Q3FY25 Performance - 31 Jan, 2025
Dr. Lal PathLabs achieved a 19% YoY increase in net profit for Q3FY25, driven by revenue growth of 11%. The company plans to open 15-20 new labs and maintain EBITDA margins while focusing on expansion in tier-three and tier-four markets.Dr Lal Pathlabs Reports Strong Q3 Growth and Dividend - 30 Jan, 2025
Dr Lal Pathlabs reported a 19% increase in Q3FY25 profit to Rs 98 crore, supported by volume growth. The company also declared a Rs 6 interim dividend for FY25, enhancing shareholder returns.Dr. Lal PathLabs Prepares for Q3 Results and Dividend - 24 Jan, 2025
Dr. Lal PathLabs is set to announce its Q3 results for FY 2024-25 on January 30, 2025, and consider a 3rd interim dividend. The company's shares dropped 2% recently, despite reporting revenue growth in Q2 FY25.Dr. Lal Pathlabs Receives CLSA Upgrade and Q3 Announcement - 23 Jan, 2025
Dr. Lal Pathlabs received an upgrade from CLSA to Outperform with a target price of ₹3,240, leading to a nearly 3% stock surge. The company also scheduled a board meeting to declare Q3 results and discuss an interim dividend.Dr. Lal Path Labs Reports Strong Earnings and Stock Surge - 07 Jan, 2025
Dr. Lal Path Labs shows robust performance with an 18.2% increase in net profit for Q2FY25. The stock surged 5% following a bulk deal, trading near crucial resistance levels.
Insights on Dr Lal Pathlabs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 9.84% to 10.25% in Dec 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Fortis Healthcare Ltd has given 36.1% return, outperforming this stock by 30.4%
- NO EFFECT
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 177.8% return, outperforming this stock by 180.5%
- NO EFFECT
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 26.82% of holdings in Dec 2024 quarter
NEGATIVE IMPACTPrice Dip
In the last 7 days, LALPATHLAB stock has moved down by -0.4%
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 53.92% to 53.91% in Dec 2024 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 129.2 Cr → 96.7 Cr (in ₹), with an average decrease of 25.2% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 6.04% to 5.82% in Dec 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 682.1 Cr → 621.8 Cr (in ₹), with an average decrease of 8.8% per quarter
Dr Lal Pathlabs Ltd Financials
Index Inclusions
Dr Lal Pathlabs Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 53.91% | ||
| Foreign Institutions | 26.82% | ||
| Mutual Funds | 10.25% | 4.14 | |
| Retail Investors | 5.82% | ||
| Others | 3.21% |
Dr Lal Pathlabs Ltd Key Indicators
Dr Lal Pathlabs Ltd Valuation
Dr Lal Pathlabs Ltd in the last 5 years
Lowest (37.51x)
November 16, 2018
Today (52.22x)
February 19, 2025
Industry (92.99x)
February 19, 2025
Highest (95.62x)
November 5, 2020
Dr Lal Pathlabs Ltd Earnings and Dividends
Dr Lal Pathlabs Ltd Earnings Results
Dr Lal Pathlabs Ltd’s net profit jumped 18.94% since last year same period to ₹96.70Cr in the Q3 2024-2025. On a quarterly growth basis, Dr Lal Pathlabs Ltd has generated -25.15% fall in its net profits since last 3-months.
Read More about Earnings ResultsDr Lal Pathlabs Ltd Dividends January,2025
In the quarter ending December 2024, Dr Lal Pathlabs Ltd has declared dividend of ₹6 - translating a dividend yield of 1.38%.
Read More about Dividends
Dr Lal Pathlabs Ltd Technicals Summary
Bearish
Neutral
Bullish
Dr Lal Pathlabs Ltd is currently in a Bearish trading position according to technical analysis indicators.
Dr Lal Pathlabs Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹21,840.22 Cr | 12.28% | 0.55 | ₹362 Cr | ₹2,226 Cr | |
| HOLD | ₹29,483.63 Cr | 104.16% | 0.67 | ₹168 Cr | ₹5,040 Cr | |
| HOLD | ₹56,694.14 Cr | 15.67% | 0.56 | ₹1,811 Cr | ₹12,667 Cr | |
| BUY | ₹9,521.57 Cr | 9.92% | 0.64 | ₹119 Cr | ₹547 Cr | |
| BUY | ₹3,805.61 Cr | 3.46% | 0.54 | ₹69 Cr | ₹571 Cr |
About Dr Lal Pathlabs Ltd
The company's top products include pathology tests, imaging tests, and preventive health check-ups. Its popular brands include Dr Lal PathLabs, Lal PathLabs, and Lal PathLabs Diagnostics. Dr Lal PathLabs Ltd has over 2000 labs across India, with more than 2000 collection centers, and over 20000 trained professionals. The company is also present in Nepal, Sri Lanka, and Bangladesh.
Dr Lal PathLabs Ltd is committed to providing quality healthcare services and products to its customers. It is ISO 9001:2015 certified and has been accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
Share Price: ₹2625.45 per share as on 20 Feb, 2025 04:01 PM
Market Capitalisation: ₹21,840.22Cr as of today
Revenue: ₹596.70Cr as on December 2024 (Q4 24)
Net Profit: ₹98.10Cr as on December 2024 (Q4 24)
Listing date: 23 Dec, 2015
Chairperson Name: Arvind Lal
| Organisation | Dr Lal Pathlabs Ltd |
| Headquarters | Gurgaon |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
FAQs on Dr Lal Pathlabs Ltd
What is Dr Lal Pathlabs Ltd price today?
Dr Lal Pathlabs Ltd share price today stands at ₹2625.45, Open: ₹2611.9, Previous Close: ₹2612.85, High: ₹2640, Low: ₹2572.5, 52 Week High: ₹3653.95, 52 Week Low: ₹1943.7.
How to Buy Dr Lal Pathlabs Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Dr Lal Pathlabs Ltd shares
Is Dr Lal Pathlabs Ltd listed on NSE?
Dr Lal Pathlabs Ltd is listed on NSE
Is Dr Lal Pathlabs Ltd listed on BSE?
Dr Lal Pathlabs Ltd is listed on BSE
What are today's High and Low prices of Dr Lal Pathlabs Ltd?
- Today's highest price of Dr Lal Pathlabs Ltd is ₹2640.
- Today's lowest price of Dr Lal Pathlabs Ltd is ₹2572.5.
What are today's traded volumes of Dr Lal Pathlabs Ltd?
Today's traded volume of Dr Lal Pathlabs Ltd(LALPATHLAB) is 1.16L.
What is today's market capitalisation of Dr Lal Pathlabs Ltd?
Today's market capitalisation of Dr Lal Pathlabs Ltd(LALPATHLAB) is ₹21840.22Cr.
What is the 52 Week High and Low Range of Dr Lal Pathlabs Ltd?
How much percentage Dr Lal Pathlabs Ltd is down from its 52 Week High?
Dr Lal Pathlabs Ltd (LALPATHLAB) share price is ₹2625.45. It is down -28.15% from its 52 Week High price of ₹3653.95
How much percentage Dr Lal Pathlabs Ltd is up from its 52 Week low?
Dr Lal Pathlabs Ltd (LALPATHLAB) share price is ₹2625.45. It is up 35.07% from its 52 Week Low price of ₹1943.7
What are the historical returns of Dr Lal Pathlabs Ltd?
What is the PE ratio of Dr Lal Pathlabs Ltd today?
PE Ratio of Dr Lal Pathlabs Ltd is 52.22
PE ratio = Dr Lal Pathlabs Ltd Market price per share / Dr Lal Pathlabs Ltd Earnings per share